These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12113905)

  • 21. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of felbamate on the pharmacokinetics of lamotrigine.
    Colucci R; Glue P; Holt B; Banfield C; Reidenberg P; Meehan JW; Pai S; Nomeir A; Lim J; Lin CC; Affrime MB
    J Clin Pharmacol; 1996 Jul; 36(7):634-8. PubMed ID: 8844446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
    Hoffmann K; Löscher W
    Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.
    Brandt C; Bethmann K; Gastens AM; Löscher W
    Neurobiol Dis; 2006 Oct; 24(1):202-11. PubMed ID: 16928449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
    Brown WM; Aiken SP
    Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Felbamate.
    Bourgeois BF
    Semin Pediatr Neurol; 1997 Mar; 4(1):3-8. PubMed ID: 9097361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.
    Marroni M; Marchi N; Cucullo L; Abbott NJ; Signorelli K; Janigro D
    Curr Drug Targets; 2003 May; 4(4):297-304. PubMed ID: 12699350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
    Löscher W; Potschka H
    J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voltage-activated calcium channels: targets of antiepileptic drug therapy?
    Stefani A; Spadoni F; Bernardi G
    Epilepsia; 1997 Sep; 38(9):959-65. PubMed ID: 9579933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2016 Oct; 109():183-195. PubMed ID: 27288003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.
    Contin M; Balboni M; Callegati E; Candela C; Albani F; Riva R; Baruzzi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):113-7. PubMed ID: 16182617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions.
    Seegers U; Potschka H; Löscher W
    Eur J Pharmacol; 2002 Sep; 451(2):149-55. PubMed ID: 12231384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.
    Lazarowski A; Ramos AJ; García-Rivello H; Brusco A; Girardi E
    Cell Mol Neurobiol; 2004 Feb; 24(1):77-85. PubMed ID: 15049512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of p38 MAPK in the Drug Resistance of Refractory Epilepsy Through the Regulation Multidrug Resistance-Associated Protein 1.
    Wang C; Hong Z; Chen Y
    Neurochem Res; 2015 Jul; 40(7):1546-53. PubMed ID: 26092535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New antiepileptic drugs in pediatric epilepsy.
    Hwang H; Kim KJ
    Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
    Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
    Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some common issues in the use of antiepileptic drugs.
    Asconapé JJ
    Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.